Homepage2607 • HKG
add
Shanghai Pharmaceuticals Holding Co Ltd
Vorige slotkoers
$Â 12,11
Dag-range
$Â 12,06 - $Â 12,32
Jaar-range
$Â 10,06 - $Â 13,68
Beurswaarde
67,54Â mld. HKD
Gem. volume
3,24Â mln.
Koers/winst
6,85
Dividendrendement
-
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | jun 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 70,83Â mld. | 2,27% |
Bedrijfskosten | 5,44Â mld. | -0,24% |
Netto inkomsten | 3,13Â mld. | 123,33% |
Netto winstmarge | 4,41 | 118,32% |
Winst per aandeel | — | — |
EBITDA | 2,74Â mld. | -8,53% |
Effectief belastingtarief | 28,14% | — |
Balans
Totale activa
Totale passiva
(CNY) | jun 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 47,55Â mld. | 6,08% |
Totale activa | 238,07Â mld. | 7,56% |
Totale passiva | 149,21Â mld. | 7,26% |
Totaal aandelenvermogen | 88,86 mld. | — |
Uitstaande aandelen | 3,71 mld. | — |
Koers-boekwaardeverhouding | 0,60 | — |
Rendement op activa | 2,44% | — |
Rendement op kapitaal | 3,85% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | jun 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 3,13Â mld. | 123,33% |
Operationele kasstroom | 3,19Â mld. | -46,68% |
Kasstroom uit beleggingen | -267,33Â mln. | -239,64% |
Kasstroom uit financiering | -110,83Â mln. | -121,61% |
Nettomutatie in liquide middelen | 2,80Â mld. | -58,10% |
Vrije kasstroom | 3,19Â mld. | -58,68% |
Over
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Opgericht
18 jan 1994
Website
Werknemers
50.120